Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08ORS
|
||||
| Former ID |
DNC012118
|
||||
| Drug Name |
6-(Allyl-methyl-amino)-4,4-diphenyl-heptan-3-ol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [533539] | ||
| Formula |
C23H31NO
|
||||
| Canonical SMILES |
CCC(C(CC(C)N(C)CC=C)(C1=CC=CC=C1)C2=CC=CC=C2)O
|
||||
| InChI |
1S/C23H31NO/c1-5-17-24(4)19(3)18-23(22(25)6-2,20-13-9-7-10-14-20)21-15-11-8-12-16-21/h5,7-16,19,22,25H,1,6,17-18H2,2-4H3
|
||||
| InChIKey |
HXWBPTAZQDKQKI-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Delta-type opioid receptor | Target Info | Inhibitor | [533539] | |
| Kappa-type opioid receptor | Target Info | Inhibitor | [533539] | ||
| Mu-type opioid receptor | Target Info | Inhibitor | [533539] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Enkephalin release | |||||
| Opioid proenkephalin pathway | |||||
| Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||